Clinical Trials on Escherichia coli Infections in Germany

Total 2504 results

University Hospital Tuebingen
Charite University, Berlin, Germany; Robert Bosch Gesellschaft für Medizinische...

Recruiting

Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19 Syndrome (YoFaPoCo)

Post-COVID-19 Syndrome | Fatigue Post Viral

Germany
CureVac
German Federal Ministry of Education and Research

Completed

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Germany
University of Ulm

Withdrawn

Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients

Liver Diseases | Virus Diseases | Hepatitis C, Chronic

Germany
Universitätsklinikum Hamburg-Eppendorf
University Hospital, Geneva; Wellcome Trust; KEMRI-Wellcome Trust Collaborative... and other collaborators

Completed

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Hemorrhagic Fever, Ebola

Germany
Seqirus
Novartis Vaccines

Completed

Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and Above

Influenza

Germany
Robert Koch Institut

Completed

Tolerability and Measurability of the Efficacy of Non Pharmaceutical Measures to Prevent Seasonal Influenza

Influenza

Germany
Novartis

Completed

Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis

Onychomycosis

France, Finland, Germany, Hungary, Iceland, Norway, Poland, Russian Federation, Spain, Turkey
Hannover Medical School
Karolinska University Hospital; Karolinska Institutet; Fondazione IRCCS Ca' Granda... and other collaborators

Recruiting

D-SOLVE Cohorts (Cohort A and B) (HDV750)

Chronic Liver Disease | HDV Infection | HDV

Germany, Italy, Romania, Sweden
Novartis Vaccines

Completed

Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult Subjects

Japanese Encephalitis | Rabies

Austria, Germany, Switzerland
Research Center Borstel

Completed

Biomarkers for Therapy Response in Drug-resistant Tuberculosis

Tuberculosis, Multidrug-resistant

Germany
B. Braun Melsungen AG

Completed

Identification of Differences in Breath Components Detected With IMS in Patients Tested on SARS-CoV-2 (COVID-19)

Covid19

Germany
University Hospital Tuebingen

Not yet recruiting

Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)

COVID-19 | ARDS

Germany
Sebastian Kelle

Completed

Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19

Myocarditis Acute

Germany
Dr. Frank Behrens
Bionorica SE

Recruiting

Effect of Bronchipret on Antiviral Immune Response in Patients With Mild COVID-19 (BroVID)

COVID-19

Germany
Research Center Borstel
Siemens Corporate Technologies

Completed

Siemens VOC TB Pilot Study

Tuberculosis

Germany
University of Cologne

Unknown

Endocarditis Registry of the University Hospital of Cologne (ER-UHC)

Infective Endocarditis

Germany
Universitätsklinikum Hamburg-Eppendorf
King's College Hospital NHS Trust

Recruiting

Multicentre Study to Record the Mental and Physical Effects of the COVID-19 Pandemic (COBESITY-Study)

Overweight and Obesity | COVID-19 Pandemic

Germany
University of Ulm

Completed

Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab Application (CasiTocCOVID)

COVID-19 | Critically Ill | Outcome, Fatal | Interleukin 6 | Tocilizumab

Germany
University of Cologne

Completed

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

HIV Infections | Acquired Immunodeficiency Syndrome

Germany
GlaxoSmithKline

Completed

Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents

Hepatitis B

Germany
Basilea Pharmaceutica

Terminated

Open-label Study of APX001 for Treatment of Patients With Invasive Mold Infections Caused by Aspergillus or Rare Molds (AEGIS)

Invasive Fungal Infections

Israel, Germany, United States, Belgium
University Hospital Goettingen
Universitätsklinikum Hamburg-Eppendorf; University Hospital, Aachen; Transplantationszentrum...

Completed

Predict Adverse Events by Covid-19 Nephritis

Covid-19

Germany
Ferrer Internacional S.A.

Completed

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

Impetigo

Germany, South Africa
IHF GmbH - Institut für Herzinfarktforschung
Ministerium für Soziales, Arbeit, Gesundheit und Demografie des Landes Rheinland-Pfalz

Completed

COVID-19 Registry Rhineland-Palatinate (Germany)

COVID

Germany
Hoffmann-La Roche

Completed

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

Hepatitis B, Chronic

Germany
Solvay Pharmaceuticals

Withdrawn

Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Germany
Bavarian Nordic

Active, not recruiting

ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects

COVID-19 Disease

Germany
University Hospital Tuebingen
University Hospital Muenster; RWTH Aachen University; University Hospital Freiburg

Withdrawn

Early Versus Late ECMO Therapy in COVID-19 Induced ARDS (ECMO-VID) (ECMO-VID)

COVID-19 | ARDS, Human

Germany
University of Ulm
Hoffmann-La Roche

Completed

Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C

Liver Diseases | Virus Diseases | Hepatitis C, Chronic

Germany
Bioverativ, a Sanofi company

Completed

A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood Transfusion (Cadenza)

Cold Agglutinin Disease

United States, United Kingdom, Israel, Australia, Spain, Austria, Germany, France, Belgium, Japan, Canada, Netherlands, Italy, Norway
Novartis Vaccines

Completed

Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults, Aged 18 Years and Above

Human Influenza

Germany
Oliver Cornely, MD
European Commission; VACCELERATE

Completed

Assessing Immune Response of Different COVID-19 Vaccines in Older Adults (EU-COVAT-1)

COVID-19 | Vaccination; Infection | Vaccination Reaction

Spain, Ireland, Germany, Norway, Lithuania
Bristol-Myers Squibb
PENTA Foundation

Completed

Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe

HIV Infection

Romania, Belgium, Germany, Italy, Spain, Switzerland, United Kingdom
University Hospital Tuebingen

Withdrawn

Test and Treat COVID 65plus+ (COVID65plus)

COVID-19 | SARS-CoV 2

Germany
University Hospital of Cologne
Clinic for Internal Medicine I, University Hospital Cologne, Germany; Institute... and other collaborators

Unknown

Clinical and Immunological Characterisation of COVID-19 in Children, Adolescents and Adults

COVID-19 | SARS-CoV-2

Germany
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008

Seasonal Influenza | Vaccine

Germany
University of Cologne

Recruiting

Leptospirosis Registry - LeptoScope (Leptoscope)

Leptospirosis

Germany
Center for Sepsis Control and Care, Germany
Center for Clinical Studies, University Hospital Jena, Germany; Dept. of Microbiology... and other collaborators

Completed

(1,3)-β-D-glucan Based Diagnosis of Invasive Candida Infection in Sepsis (CandiSep)

Septic Shock | Severe Sepsis

Germany
Hepatera Ltd.
Data Matrix Solutions

Completed

A Multicenter, Open-label, Randomized Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D

Chronic Hepatitis D Infection With Hepatitis B

Russian Federation, Germany
Abbott Biologicals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 Season

Prophylaxis of Influenza

Germany
RWTH Aachen University

Recruiting

Respiratory Muscles After Hospitalisation for COVID-19 (REMAP-COVID-19)

Covid19 | Diaphragm Injury

Germany
University Medicine Greifswald

Active, not recruiting

Adaptive Immune Response to COVID-19 Vaccination (AICOVI)

SARS-CoV-2 Vaccination

Germany
University of Giessen
Universitätsklinikum Hamburg-Eppendorf

Completed

Kidney Histopathology After COVID-19 and SARS-CoV-2 Vaccination

Covid19 | Vaccination Reaction

Germany
Novartis Vaccines

Completed

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2008/2009

Seasonal Influenza, Vaccine

Germany
Pfizer

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Tick-borne Encephalitis

Austria, Germany, Poland
Dr. Panagiota Manava

Completed

Impact of Covid-19 in the Emergency Department

COVID-19

Germany
Enanta Pharmaceuticals, Inc

Completed

Two-way Interaction Between Alisporivir and EDP239

Hepatitis C Virus

Germany
University Hospital, Essen
Federal Ministry of Education and Reserach (BMBF)

Completed

Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study)

Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection. | Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors, | HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral...

Germany
Charite University, Berlin, Germany

Terminated

Prevalence of CVC-associated Sepsis and Use of Blood Cultures in Berlin - Brandenburg

Bacteremia

Germany
Impatients N.V. trading as myTomorrows
Inmunotek S.L.

No longer available

Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)

Urinary Tract Infections | Bladder Infection | Recurrent Urinary Tract Infection | Urinary Tract Infection Bacterial | Chronic Urinary Tract Infection

Czechia, Denmark, Serbia, France, Germany, Turkey, Belgium, Finland, Luxembourg, Netherlands, Norway, Romania, Slovakia, Slovenia, Sweden

Clinical Trials on Escherichia coli Infections in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations